
NovaBay Pharmaceuticals Tumbles 9% in After Hours; Guess (GES) Down as Well
NovaBay Pharmaceuticals (NYSEMKT:NBY) is lower in late trading after the clinical-stage biopharmaceutical company said late Wednesday that it intends to offer shares of its common stock and warrants in an underwritten public offering. Shares are down 8.73% at $1.15, with a 52-week range of $0.76 – $2.03. The company intends to use the net proceeds from this offering for working capital and general corporate purposes, … Continue reading NovaBay Pharmaceuticals Tumbles 9% in After Hours; Guess (GES) Down as Well